State of the County breakfast was held Feb. 21 at Mineral Area College in the Cardinal Center in the Industry and Technology ...

Granules added that manufacturing and distribution of its existing products at the facility will continue unaffected.

Granules India's shares fell nearly 8% after the US FDA issued a warning letter regarding its Gagillapur facility, citing ...

IREDA shares slipped 6.43 per cent to Rs 155.75. Deepak Fertilisers declined 6.81 per cent to Rs 957.75. Redington lost 6.38 ...

"On February 26, 2025, the US FDA issued a Warning Letter to Granules' Gagillapur facility based on its inspection conducted ...

TP Solar Limited, Tata Power’s solar manufacturing arm, has bagged a Rs 632 crore worth contract from SECI. The Tata group ...

The Warning Letter is dated February 26, 2025 and the facility continues to hold an "Official Action Indicated" (OAI) status.

Your roof is your home’s first line of defense against the elements, but like any part of your house, it won’t last forever.

The USFDA issued a warning letter to Granules India Ltd's Gagillapur facility after an August 2024 inspection highlighted ...

Granules India's Gagillapur facility receives FDA warning letter, impacting product submissions review until resolved, company remains confident in resolution.

The development may temporarily delay the approval of pending product submissions from the site, but existing manufacturing ...

Drug firm Granules India Ltd on Thursday (February 27) announced that the US FDA has issued a Warning Letter for its ...